Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Autoimmune Disorders

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 69 articles:
HTML format
Text format



Single Articles


    October 2019
  1. SABBAGH S, Almeida de Jesus A, Hwang S, Kuehn HS, et al
    Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.
    Brain. 2019 Oct 11. pii: 5585662. doi: 10.1093.
    PubMed     Text format    


  2. LANDON-CARDINAL O, Benveniste O, Allenbach Y
    Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.
    Brain. 2019 Oct 11. pii: 5585663. doi: 10.1093.
    PubMed     Text format    


  3. CRISP SJ, Dixon CL, Jacobson L, Chabrol E, et al
    Glycine receptor autoantibodies disrupt inhibitory neurotransmission.
    Brain. 2019 Oct 8. pii: 5583666. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. NUTMA E, Stephenson JA, Gorter RP, de Bruin J, et al
    A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Brain. 2019 Oct 3. pii: 5580333. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. KARAKAYA M, Wirth B
    Hereditary nodo-paranodopathies: genomic variants, not just autoantibodies, hit the protein.
    Brain. 2019;142:2895-2897.
    PubMed     Text format    


    September 2019
  6. ELLIOTT C, Belachew S, Wolinsky JS, Hauser SL, et al
    Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
    Brain. 2019;142:2787-2799.
    PubMed     Text format     Abstract available


  7. PENNER IK, Hartung HP
    The dark side of the moon: looking beyond beneficial effects of cannabis use in multiple sclerosis.
    Brain. 2019;142:2552-2555.
    PubMed     Text format    


  8. BENVENISTE O, Allenbach Y
    Inclusion body myositis: accumulation of evidence for its autoimmune origin.
    Brain. 2019;142:2549-2551.
    PubMed     Text format    


    August 2019
  9. MORQUETTE B, Juzwik CA, Drake SS, Charabati M, et al
    MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis.
    Brain. 2019 Aug 14. pii: 5549993. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. BROWNLEE WJ, Altmann DR, Prados F, Miszkiel KA, et al
    Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brain. 2019;142:2276-2287.
    PubMed     Text format     Abstract available


    July 2019
  11. FEINSTEIN A, Meza C, Stefan C, Staines RW, et al
    Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
    Brain. 2019 Jul 30. pii: 5541023. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. WENTLING M, Lopez-Gomez C, Park HJ, Amatruda M, et al
    A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis.
    Brain. 2019 Jul 15. pii: 5531715. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. HAUSLER D, Torke S, Peelen E, Bertsch T, et al
    High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium.
    Brain. 2019 Jul 13. pii: 5532100. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. FITZGERALD KC, Kim K, Smith MD, Aston SA, et al
    Early complement genes are associated with visual system degeneration in multiple sclerosis.
    Brain. 2019 Jul 9. pii: 5530228. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. ROPELE S, Fazekas F
    Quantification of cortical damage in multiple sclerosis using DTI remains a challenge.
    Brain. 2019;142:1848-1850.
    PubMed     Text format    


    June 2019
  16. FILIPPI M, Preziosa P, Banwell BL, Barkhof F, et al
    Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
    Brain. 2019 Jun 17. pii: 5519813. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. PREZIOSA P, Kiljan S, Steenwijk MD, Meani A, et al
    Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex.
    Brain. 2019 Jun 5. pii: 5511700. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2019
  18. MUNK NIELSEN N, Corn G, Frisch M, Stenager E, et al
    Multiple sclerosis among first- and second-generation immigrants in Denmark: a population-based cohort study.
    Brain. 2019 May 13. pii: 5488579. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. COTZOMI E, Stathopoulos P, Lee CS, Ritchie AM, et al
    Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.
    Brain. 2019 May 5. pii: 5485817. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. GIOVANNONI G
    Survival: the ultimate long-term outcome in multiple sclerosis.
    Brain. 2019;142:1166-1167.
    PubMed     Text format    


    April 2019
  21. VAN COEVORDEN-HAMEETE MH, de Bruijn MAAM, de Graaff E, Bastiaansen DAEM, et al
    The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.
    Brain. 2019 Apr 22. pii: 5476117. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. WEKERLE H
    Secondary progressive multiple sclerosis and the gut-brain axis.
    Brain. 2019;142:838-840.
    PubMed     Text format    


    March 2019
  23. KINGWELL E, Leray E, Zhu F, Petkau J, et al
    Multiple sclerosis: effect of beta interferon treatment on survival.
    Brain. 2019 Mar 18. pii: 5382233. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. HOHLFELD R
    Immune dysbalance in childhood multiple sclerosis: a 'chicken or the egg' conundrum.
    Brain. 2019;142:490-492.
    PubMed     Text format    


    February 2019
  25. KADOWAKI A, Saga R, Lin Y, Sato W, et al
    Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.
    Brain. 2019 Feb 15. pii: 5321131. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. MEXHITAJ I, Nyirenda MH, Li R, O'Mahony J, et al
    Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis.
    Brain. 2019 Feb 12. pii: 5316384. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. ALLENBACH Y, Bolko L, Toquet S, Landon-Cardinal O, et al
    Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.
    Brain. 2019 Feb 1. pii: 5305679. doi: 10.1093.
    PubMed     Text format    


  28. PAPADOPOULOU C, Hong Y, Omoyinmi E, Brogan PA, et al
    Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.
    Brain. 2019 Feb 1. pii: 5305681. doi: 10.1093.
    PubMed     Text format    


    January 2019
  29. EDEN D, Gros C, Badji A, Dupont SM, et al
    Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Brain. 2019 Jan 30. pii: 5304670. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. NTRANOS A, Ntranos V, Bonnefil V, Liu J, et al
    Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis.
    Brain. 2019 Jan 28. pii: 5303708. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. CHEN Y, Podojil JR, Kunjamma RB, Jones J, et al
    Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis.
    Brain. 2019 Jan 17. pii: 5289373. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2018
  32. VON ESSEN MR, Ammitzboll C, Hansen RH, Petersen ERS, et al
    Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.
    Brain. 2018 Dec 17. pii: 5250831. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. KAUNZNER UW, Kang Y, Zhang S, Morris E, et al
    Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.
    Brain. 2018 Dec 15. pii: 5250435. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2018
  34. ZALC B
    One hundred and fifty years ago Charcot reported multiple sclerosis as a new neurological disease.
    Brain. 2018 Nov 20. pii: 5194497. doi: 10.1093.
    PubMed     Text format    


  35. ALY L, Korn T
    Multiple sclerosis: is it all black and white in optical coherence tomography?
    Brain. 2018;141:3088-3091.
    PubMed     Text format    


  36. DEBANNE D, El Far O
    Pre- and postsynaptic effects of LGI1 autoantibodies in a murine model of limbic encephalitis.
    Brain. 2018;141:3092-3095.
    PubMed     Text format    


  37. AESCHLIMANN FA, Fremond ML, Duffy D, Rice GI, et al
    A child with severe juvenile dermatomyositis treated with ruxolitinib.
    Brain. 2018;141:e80.
    PubMed     Text format    


  38. ALLENBACH Y, Toquet S, Landon-Cardinal O, Benveniste O, et al
    Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib.
    Brain. 2018;141:e81.
    PubMed     Text format    


    October 2018
  39. CALDITO NG, Saidha S, Sotirchos ES, Dewey BE, et al
    Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.
    Brain. 2018 Oct 11. pii: 5127751. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. DOETS AY, Verboon C, van den Berg B, Harbo T, et al
    Regional variation of Guillain-Barre syndrome.
    Brain. 2018;141:2866-2877.
    PubMed     Text format     Abstract available


    September 2018
  41. BAKER D, Pryce G, Amor S, Giovannoni G, et al
    Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis.
    Brain. 2018 Sep 12. pii: 5095715. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. EIJLERS AJC, van Geest Q, Dekker I, Steenwijk MD, et al
    Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Brain. 2018;141:2605-2618.
    PubMed     Text format     Abstract available


    June 2018
  43. MACHADO-SANTOS J, Saji E, Troscher AR, Paunovic M, et al
    The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
    Brain. 2018 Jun 4. pii: 5032773. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. STANKOFF B, Louapre C
    Can we use regional grey matter atrophy sequence to stage neurodegeneration in multiple sclerosis?
    Brain. 2018;141:1580-1583.
    PubMed     Text format    


    May 2018
  45. CAMARA-LEMARROY CR, Metz L, Meddings JB, Sharkey KA, et al
    The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.
    Brain. 2018 May 30. pii: 5025744. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. BARRO C, Benkert P, Disanto G, Tsagkas C, et al
    Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Brain. 2018 May 30. pii: 5025690. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. ESHAGHI A, Marinescu RV, Young AL, Firth NC, et al
    Progression of regional grey matter atrophy in multiple sclerosis.
    Brain. 2018 May 8. pii: 4993898. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. LADISLAU L, Suarez-Calvet X, Toquet S, Landon-Cardinal O, et al
    JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.
    Brain. 2018 May 8. pii: 4993951. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  49. CONRAD BN, Barry RL, Rogers BP, Maki S, et al
    Multiple sclerosis lesions affect intrinsic functional connectivity of the spinal cord.
    Brain. 2018 Apr 10. pii: 4965865. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. VAN LANGELAAR J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, et al
    T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention.
    Brain. 2018 Apr 5. pii: 4961484. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  51. STEYERBERG EW, Claggett B
    Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919652. doi: 10.1093.
    PubMed     Text format    


  52. KALINCIK T
    Reply: Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919653. doi: 10.1093.
    PubMed     Text format    


  53. STEPHENSON EL, Mishra MK, Moussienko D, Laflamme N, et al
    Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
    Brain. 2018 Mar 1. pii: 4915907. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  54. ARRAMBIDE G, Tintore M, Espejo C, Auger C, et al
    The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.
    Brain. 2018 Feb 16. pii: 4866204. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  55. SMETS I, Fiddes B, Garcia-Perez JE, He D, et al
    Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.
    Brain. 2018 Jan 18. pii: 4817414. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  56. KIM RY, Mangu D, Hoffman AS, Kovash R, et al
    Oestrogen receptor beta ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis.
    Brain. 2017 Dec 8. pii: 4710057. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  57. GRANBERG T, Fan Q, Treaba CA, Ouellette R, et al
    In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Brain. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  58. ROCCA MA, Sormani MP, Rovaris M, Caputo D, et al
    Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.
    Brain. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. DATTA G, Colasanti A, Rabiner EA, Gunn RN, et al
    Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Brain. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. KALINCIK T, Manouchehrinia A, Sobisek L, Jokubaitis V, et al
    Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
    Brain. 2017;140:2426-2443.
    PubMed     Text format     Abstract available


    July 2017
  61. SCOLDING NJ, Pasquini M, Reingold SC, Cohen JA, et al
    Cell-based therapeutic strategies for multiple sclerosis.
    Brain. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  62. DELMONT E, Manso C, Querol L, Cortese A, et al
    Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
    Brain. 2017 May 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. ZRZAVY T, Hametner S, Wimmer I, Butovsky O, et al
    Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.
    Brain. 2017 May 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  64. HACOHEN Y, Ciccarelli O, Hemingway C
    Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination.
    Brain. 2017;140:1172-1174.
    PubMed     Text format    


    April 2017
  65. EL BEHI M, Sanson C, Bachelin C, Guillot-Noel L, et al
    Adaptive human immunity drives remyelination in a mouse model of demyelination.
    Brain. 2017;140:967-980.
    PubMed     Text format     Abstract available


    March 2017
  66. LONGONI G, Brown RA, MomayyezSiahkal P, Elliott C, et al
    White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.
    Brain. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. JURYNCZYK M, Geraldes R, Probert F, Woodhall MR, et al
    Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
    Brain. 2017;140:617-627.
    PubMed     Text format     Abstract available


    February 2017
  68. PONATH G, Ramanan S, Mubarak M, Housley W, et al
    Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.
    Brain. 2017;140.
    PubMed     Text format     Abstract available


    June 2016
  69. ARAUJO AQ, Silva MT, Araujo AP
    Zika virus-associated neurological disorders: a review.
    Brain. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: